ADPT logo

Adaptive Biotechnologies Corporation Common Stock

ADPT

ADPT: Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease ("MRD") in patients with multiple myeloma ("MM"), B cell acute lymphoblastic leukemia ("ALL") and chronic lymphocytic leukemia ("CLL") and is also available as a CLIA-validated laboratory developed test ("LDT") for patients with other lymphoid cancers, including diffuse large B-cell lymphoma ("DLBCL").

more

Show ADPT Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of ADPT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by ADPT's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $60,000 Jul 18, 2023 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
  • $80,000 Apr 13, 2023 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
  • $10,000 Feb 02, 2023 Issue: Medical/Disease Research/Clinical Labs
  • $70,000 Jan 18, 2023 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
  • $80,000 Oct 17, 2022 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
  • $70,000 Jul 12, 2022 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $240,000 Mar 23, 2022 Issue: Medicare/Medicaid Health Issues
  • $190,000 Jan 21, 2022 Issue: None
  • $140,000 Oct 20, 2021 Issue: None
  • $120,000 Jul 15, 2021 Issue: None
  • $130,000 Apr 20, 2021 Issue: HEALTH ISSUES
  • $190,000 Jan 21, 2021 Issue: HEALTH ISSUES
  • $80,000 Oct 20, 2020 Issue: Health Issues Medicare/Medicaid
  • $50,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $30,000 Apr 20, 2015 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
U.S. Patents

New patents grants

  • Patent Title: Synthetic strands for nucleic acid sequencing and related methods and systems Jul. 25, 2023
  • Patent Title: Determining wt-1 specific t cells and wt-1 specific t cell receptors (tcrs) Jul. 19, 2022
  • Patent Title: Determining antigen-specific t-cells Mar. 01, 2022
  • Patent Title: Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements Feb. 22, 2022
  • Patent Title: Methods using randomer-containing synthetic molecules Feb. 15, 2022
  • Patent Title: Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization Nov. 23, 2021
  • Patent Title: Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing Jul. 20, 2021
  • Patent Title: Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing Jun. 29, 2021
  • Patent Title: Method of identifying human compatible t cell receptors specific for an antigenic target Jun. 22, 2021
  • Patent Title: Monitoring health and disease status using clonotype profiles Jun. 01, 2021
  • Patent Title: Methods of monitoring conditions by sequence analysis May. 11, 2021
  • Patent Title: Compositions and methods for measuring and calibrating amplification bias in multiplexed pcr reactions Jan. 19, 2021
  • Patent Title: Monitoring health and disease status using clonotype profiles Dec. 15, 2020
  • Patent Title: Monitoring health and disease status using clonotype profiles Sep. 01, 2020
  • Patent Title: Method for genotyping clonotype profiles using sequence tags Jan. 07, 2020
  • Patent Title: Monitoring health and disease status using clonotype profiles Dec. 31, 2019
  • Patent Title: Determining antigen-specific t-cells Oct. 08, 2019
  • Patent Title: Identification of antigen-specific b cell receptors Oct. 01, 2019
  • Patent Title: Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples Aug. 27, 2019
  • Patent Title: Random array sequencing of low-complexity libraries Aug. 20, 2019
  • Patent Title: Adaptive immunity profiling and methods for generation of monoclonal antibodies Jun. 18, 2019
  • Patent Title: Methods of monitoring conditions by sequence analysis Apr. 23, 2019
  • Patent Title: Methods of monitoring conditions by sequence analysis Apr. 02, 2019
  • Patent Title: Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture Apr. 02, 2019
  • Patent Title: Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization Mar. 05, 2019
  • Patent Title: Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions Feb. 26, 2019
  • Patent Title: Monitoring health and disease status using clonotype profiles Dec. 18, 2018
  • Patent Title: Quantification of adaptive immune cell genomes in a complex mixture of cells Dec. 11, 2018
  • Patent Title: Determining paired immune receptor chains from frequency matched subunits Sep. 18, 2018
  • Patent Title: Method for genotyping clonotype profiles using sequence tags Sep. 18, 2018
  • Patent Title: Determining antigen-specific t-cells Sep. 04, 2018
  • Patent Title: Diagnosis of lymphoid malignancies and minimal residual disease detection Nov. 21, 2017
  • Patent Title: Method for generating clonotype profiles using sequence tags Jul. 18, 2017
  • Patent Title: Rare clonotypes and uses thereof Dec. 27, 2016
  • Patent Title: Sequence analysis of complex amplicons Dec. 20, 2016
  • Patent Title: Monitoring health and disease status using clonotype profiles Dec. 06, 2016
  • Patent Title: Method of sequence determination using sequence tags Nov. 29, 2016
  • Patent Title: Detection and measurement of tissue-infiltrating lymphocytes Nov. 22, 2016
  • Patent Title: Monitoring health and disease status using clonotype profiles Aug. 16, 2016
  • Patent Title: Detection and quantification of sample contamination in immune repertoire analysis Jul. 19, 2016
  • Patent Title: Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions Jun. 21, 2016
  • Patent Title: Monitoring immunoglobulin heavy chain evolution in b-cell acute lymphoblastic leukemia Jun. 14, 2016
  • Patent Title: Single cell analysis by polymerase cycling assembly May. 24, 2016
  • Patent Title: Quantification of adaptive immune cell genomes in a complex mixture of cells Mar. 08, 2016
  • Patent Title: Quantification of adaptive immune cell genomes in a complex mixture of cells Nov. 10, 2015
  • Patent Title: Quantification of adaptive immune cell genomes in a complex mixture of cells Nov. 10, 2015
  • Patent Title: Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions Oct. 06, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of ADPT in WallStreetBets Daily Discussion

ADPT News

Recent insights relating to ADPT

CNBC Recommendations

Recent picks made for ADPT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ADPT

Corporate Flights

Flights by private jets registered to ADPT